Navigation Links
Shire's Replenished Portfolio Drives Excellent Quarterly Performance
Date:4/29/2010

authorized generic versions of ADDERALL XR by Teva and Impax in April and October 2009, and the inclusion of lower margin sales of the authorized generic to Teva and Impax which depressed gross margins for ADDERALL XR.

    Research and development ("R&D")

                                              % of                  % of
                                           product               product
                              Q1 2010        sales  Q1 2009        sales
                                   $M                    $M
    R&D (US GAAP)               131.0          18%    185.9          25%
    Women's Health exit costs       -                (65.0)
    Depreciation                (3.7)                 (4.0)
    R&D (Non GAAP)              127.3          18%    116.9          15%

Non GAAP R&D increased in absolute terms by $10.4 million in 2010 over 2009 due to continued increased investment in R&D programs, in part as a result of acceleration of the REPLAGAL and VPRIV programs. As a percentage of core product sales, Non GAAP R&D decreased by 5 percentage points to 20% (2009: 25%).

    Selling, general and administrative ("SG&A")

                                            % of              % of
                                         product           product
                                Q1 2010    sales  Q1 2009    sales
                                     $M                $M
    SG&A (US GAAP)                359.9      50%    318.9      42%
    Intangible asset             (34.6)            (32.5)
    amortization
    Depreciation                 (16.3)            (14.8)
    SG&A (Non GAAP)               309.0      43%    271.6      36%

Non GAAP SG&A increased in 2010 compared to 2009 due in part to increased selling and marketing costs incurred in
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio
2. ClearTrial to Demonstrate How a Top 20 Sponsor Achieved -1 Percent Cost Variance Across Their $130M Clinical Portfolio at Major Industry Conference
3. EUCODIS Bioscience Receives EUR 2 Million Cash Injection to Enlarge Product Portfolio and Develop International Markets
4. New Industry Research Identifies "Operational Gap" in Clinical Trial Portfolio Management
5. Karolinska Development Expands its Life Science Portfolio With BioChromix Pharma
6. MedImmune Highlights Inflammatory Disease Portfolio at 73rd Annual Meeting of the American College of Rheumatology
7. The Pittsburgh Life Sciences Greenhouse Invests $725K in Portfolio Companies
8. Octapharma Aims to Expand U.S. Immune Globulin Therapy Portfolio
9. EUCODIS Bioscience Launches Lipase Portfolio
10. PharmaVentures Corporate Advisory Appoints Nikki Watkins as Practice Head, Product & Portfolio Strategy
11. Karolinska Development Portfolio Company Completes Successful Phase II Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 According to ... (1D & 2D Gel Electrophoresis, Agarose & Polyacrylamide Gel, ... Informatics), by Application & by End User - Global ... is expected to reach around $1.98 Billion by 2020 ... 2015 to 2020. Browse 226 ma ...
(Date:5/21/2015)... - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: ... commercializes proprietary technologies and products for advanced microarray diagnostics, ... second fiscal quarter ended March 31, 2015. ... business with our existing customers and to develop new ... of SQI. "The delivery of a fully automated sqidlite™ ...
(Date:5/21/2015)... YORK , May 21, 2015  Prima Biomed ... company that is striving to become a leader in ... cancer, recently announced that the final CVac data from ... shown a clear trend for a clinically meaningful improvement ... in second remission patients. In the group ...
(Date:5/21/2015)... W. R. Grace & Co. ... Worms, Germany has received good manufacturing practice (GMP) ... International Pharmaceutical Excipient Council (IPEC) Foundation. ... SYLOID® FP brand of pharmaceutical grade excipient silica ... Curtis Bay, Maryland (USA) and Sorocaba, Brazil locations. ...
Breaking Biology Technology:Electrophoresis Market Worth $1.98 Billion by 2020 2Electrophoresis Market Worth $1.98 Billion by 2020 3Electrophoresis Market Worth $1.98 Billion by 2020 4SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8Correction Continues after Big Move - BrokerBank Securities, Inc. 2Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2
... , CHARLESTON, S.C., Oct. 13 Jeremy M. Stipkala, ... Developments" at the Southeastern Regional Meeting of the American ... The conference will be held October 21-24, 2009 ... Juan, Puerto Rico. , Dr. Stipkala, a ...
... 13, 2009 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) ... quarter of 2009 on Tuesday, October 20, 2009 at 5:00 ... chief executive officer, will lead the call. On the same ... quarter of 2009. , The call will be webcast live ...
... BEIJING, Oct. 13 /PRNewswire-Asia/ -- Sinovac Biotech Ltd.,(NYSE Amex: ... vaccines in China,announced today that its wholly-owned subsidiary, Sinovac ... to distribute Panflu(TM) (H5N1),its H5N1 (bird flu) pandemic influenza ... 13, 2014 and thereafter will be renewable for,periods of ...
Cached Biology Technology:Amylin Pharmaceuticals to Webcast Third Quarter Results 2Sinovac Receives Certificate of Approval to Distribute Panflu (H5N1) Vaccine in Hong Kong 2Sinovac Receives Certificate of Approval to Distribute Panflu (H5N1) Vaccine in Hong Kong 3
(Date:4/14/2015)... Conn. , April 14, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... been nominated for the 2015 New York Design Awards ... The Design100, New York City Design Awards are part ... based on over 2,500 ratings from the marketplace, industry ...
(Date:4/10/2015)... 2015 Research and Markets ( ... "Security Competitive Profiles - NEC" report to their ... NEC will continue to supply a range of IT ... a company focus on the development of a Big ... opportunities in the Asia-Pacific region ...
(Date:4/6/2015)... , Apr. 6, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... provisional patent 62/143028 for MINIATURE, MULTI-PURPOSE ... TRANSFER  NXT-ID introduces a new revolutionary ... patent surrounds the use of miniature antenna modules ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3NEC Security Competitive Profile 2015 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... of Minnesota researcher has found a universal rule that regulates ... that may also offer a key to calculating their carbon ... order to construct valid models of global carbon dioxide cycling. ... and animals through the process of respiration; Peter Reich, a ...
... A recent study shows that hundreds of genes contribute ... time these genes, many of which are potential contributors ... study. , The group led by Professor Jussi Taipale ... Finland) has identified genes contributing to cell growth and ...
... against the bird flu virus H5N1, derived from horses, ... virus. , A study published today in the ... that a dose of 100 µg of horse anti-serum ... antibodies developed in horses could potentially be used to ...
Cached Biology News:Of mice, men, trees and the global carbon cycle 2Of mice, men, trees and the global carbon cycle 3Genes involved in cell growth and cell division identified 2
... Ideal for hand-held applications or for use ... with a hand-held eight-port disposable manifold provides ... a multi-channel pipette. The StatMatic II can ... sizes and can completely fill a microplate ...
... thermal cycler is a completely redesigned and ... and it accepts the full line of ... same precision in thermal performance as the ... cyclers, allowing easy transport of protocols among ...
... These 2-D standards consist of seven reduced, ... bovine carbonic anhydrase, rabbit muscle GAPDH, bovine ... conalbumin) with pIs ranging from 4.5 to ... to 76,000. These 2-D standards provide calibrated ...
The sealed ice cooling unit is used to absorb heat that is generated during transfers performed in the Criterion blotter....
Biology Products: